Saturday, January 15 (14)

8:30 AM - 10:00 AM

Plenary Session III: Late-Breaking Clinical Trials Featured

The Late-Breaking Clinical Trial session emphasizes the most recent and groundbreaking research in the field of neuromodulation.


Ellen L. Air, MD PhD; Nebojsa Nick Knezevic, MD PhD

Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy-18-Month Multicenter Randomized Controlled Trial Results (Abstract ID# 16457)

Erika Petersen, MD

Determining the Prognostic Value of Continuous Intrathecal Infusion (Abstract ID# 16264)

Bradford Jones, DO

The influence of stimulation frequency in DRG stimulation – a double-blind randomized trial (Abstract ID# 16240)

Guilherme Santos Piedade, MD

Twelve-month outcomes from RCT: 10kHz Spinal Cord Stimulation for treating Non-surgical Refractory Back Pain (Abstract ID# 16473)

Leonardo Kapural, MD PhD

Closing Q&A Discussion

John Markman, MD

Anuj Bhatia, MD PhD

10:30 AM - 12:00 PM

Brain Neuromodulation - Where Is the Evidence for What We Do? (CNS Session)

The accepted indications for brain neuromodulation are growing. However, what is the quality of the scientific evidence behind the current clinical uses of brain neuromodulation? This session will explore the extant level of evidence behind brain neuromodulation for a variety of neurologic disorders

Subscribe to this RSS feed